Although the AKT-BIM pathway is important in the chemo-sensitivity and apoptosis of cancer cells, whether AKT regulates BIM activity in ovarian cancer cells during ATO treatment remains unclear. Here, BCL2L11 is linked to ovarian carcinoma.